Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.

More about this publication

Nature medicine
  • Publication date 06-03-2024

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.